An international collaboration of genetic researchers has identified more than 90 genetic regions associated with the risk of ...

Learn how newly discovered genetic regions may help explain Alzheimer’s risk, pointing to brain immune cells, neurons, and ...

Please provide your email address to receive an email when new articles are posted on . Cell transformation begins with slow degeneration and progresses rapidly. The data confirmed results from ...

Buntanetap, a pill being tested in the US, improved memory in some Alzheimer's patients and has previously shown benefits in ...

Alzheimer's patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows. The analysis found Alzheimer's disease continued to progress ...

Quantile aggregation may lead to overstated claims about amyloid-cognition relationships ...

Omics analysis is the process of analyzing large data sets to extract meaningful information about biological molecules—genes, DNA, RNA, proteins, metabolites or more—with the goal of illuminating ...

Integrated mass spectrometry imaging and spatial transcriptomics reveal that amyloid-β plaques differ in composition and local tissue responses, offering insight into Alzheimer’s disease heterogeneity ...

The researchers, working under the banner of the International Genomics of Alzheimer’s Project (I-GAP), used a method of discovery known as case–control genome-wide association studies (GWASs). In ...

Trials of monoclonal antibodies that target various forms of amyloid at different stages of Alzheimer’s disease have had mixed results. We tested solanezumab, which targets monomeric amyloid, in a ...

Jan 4 (Reuters) - Emergency treatment with a blood clot buster called tissue plasminogen activator for a patient who had a stroke while being treated with the experimental Alzheimer's drug lecanemab ...